We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Antengene, a commercial-stage global biopharmaceutical company, and Hansoh Pharmaceutical Group Company have collaborated for the commercialisation of Antengene’s product Xpovio within mainland China. Xpovio, designed to treat adult
Regeneron Pharmaceuticals has announced its intention to purchase Decibel Therapeutics, a biotechnology company in the clinical stage, in a transaction valued at roughly $109m. Decibel Therapeutics is focused
ADARx Pharmaceuticals, a biotechnology company in the clinical stage that specialises in developing advanced RNA therapeutics, has announced the successful conclusion of an oversubscribed Series C financing round,
Aspen Neuroscience has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application, which allows the company to move forward with
Ginkgo Bioworks, a company at the forefront of cell programming and biosecurity, has unveiled a fresh partnership with Merck, recognised as MSD beyond the borders of the US
Ionis Pharmaceuticals and Novartis have joined hands in a collaboration and license agreement aimed at discovering, developing, and bringing to market an innovative medicine designed specifically for patients
FACIT (Fight Against Cancer Innovation Trust) and the University of Toronto’s Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM) have joined forces in a partnership
Grünenthal and Kyowa Kirin have completed a deal to establish a Joint Venture Collaboration focused on Kyowa Kirin International’s established medicines portfolio. The portfolio includes 13 brands across
Everest Medicines has enrolled patients for the China open-label extension (cOLE) of the Phase 3 NefIgArd study. This extension study will provide an additional nine months of treatment
Sanofi, a global pharmaceutical company, has reached a definitive agreement to acquire Qunol, a well-established brand in the health and wellness industry based in the US. The acquisition